Stephen Fowler Flatt - 12 Mar 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen Flatt
Issuer symbol
NHC
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 16:10:07 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Flatt Stephen Fowler CEO, Director 100 VINE STREET, MURFREESBORO /s/ Stephen Flatt 16 Mar 2026 0001330766

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise +1,853 +2.9% $53.94* 65,505 12 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise -1,853 -30% $0.000000* 4,294 12 Mar 2026 Common Stock 6,147 $53.94 Direct F1
holding NHC Option to Purchase Common Stock 10,000 12 Mar 2026 Common Stock 10,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 13,000 12 Mar 2026 Common Stock 13,000 $90.62 Direct
holding NHC Option to Purchase Common Stock 20,000 12 Mar 2026 Common Stock 20,000 $157.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).